148 related articles for article (PubMed ID: 9560111)
1. Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
Gendeh BS; Gibb AG; Aziz NS; Kong N; Zahir ZM
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):551-8. PubMed ID: 9560111
[TBL] [Abstract][Full Text] [Related]
2. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
3. Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis.
Gendeh BS; Said H; Gibb AG; Aziz NS; Kong N; Zahir ZM
J Laryngol Otol; 1993 Aug; 107(8):681-5. PubMed ID: 8409715
[TBL] [Abstract][Full Text] [Related]
4. Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD.
Tokgoz B; Somdas MA; Ucar C; Kocyigit I; Unal A; Sipahioglu MH; Oymak O; Utas C
Ren Fail; 2010 Jan; 32(2):179-84. PubMed ID: 20199179
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.
Tokgoz B; Ucar C; Kocyigit I; Somdas M; Unal A; Vural A; Sipahioglu M; Oymak O; Utas C
Nephrol Dial Transplant; 2011 Dec; 26(12):4073-8. PubMed ID: 21551083
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
Montañés Pauls B; Almiñana MA; Casabó Alós VG
Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
[TBL] [Abstract][Full Text] [Related]
7. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
10. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
[TBL] [Abstract][Full Text] [Related]
11. Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin.
van der Hulst RJ; Boeschoten EW; Nielsen FW; Struijk DG; Dreschler WD; Tange RA
ORL J Otorhinolaryngol Relat Spec; 1991; 53(1):19-22. PubMed ID: 2008289
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
[TBL] [Abstract][Full Text] [Related]
13. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
[TBL] [Abstract][Full Text] [Related]
14. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
Blunden M; Zeitlin D; Ashman N; Fan SL
Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
[TBL] [Abstract][Full Text] [Related]
16. Once weekly intraperitoneal therapy for gram-positive peritonitis.
Morse GD; Nairn DK; Walshe JJ
Am J Kidney Dis; 1987 Oct; 10(4):300-5. PubMed ID: 3661551
[TBL] [Abstract][Full Text] [Related]
17. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
Bailie GR; Morton R; Ganguli L; Keaney M; Waldek S
Nephron; 1987; 46(3):316-8. PubMed ID: 3627326
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
Mounier M; Benevent D; Denis F
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy.
Boyce NW; Wood C; Thomson NM; Kerr P; Atkins RC
Am J Kidney Dis; 1988 Oct; 12(4):304-6. PubMed ID: 3177373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
